Hepatitis A and E virus antibodies in Chilean children of low socioeconomic status. A one year follow-up study;Seguimiento de anticuerpos contra hepatitis A y E en una cohorte de niños de bajo nivel socioeconómico

Revista Medica de Chile

Volumn 134, Issue 2, 2006, Pages 139-144

  Humberto Ibarra, V ^a,b   Stella Riedemann, G ^a   Claudio Toledo, A ^a  

^a UNIVERSIDAD AUSTRAL DE CHILE   (Chile)

^b NONE   (Chile)

Author keywords

Hepatitis A; Hepatitis A antibodies; Hepatitis E; Hepatitis, viral, human

Indexed keywords

HEPATITIS ANTIBODY;

ARTICLE; BLOOD; CHILE; COHORT ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIOLOGY; FEMALE; FOLLOW UP; HEPATITIS A; HEPATITIS A VIRUS; HEPATITIS E; HEPATITIS E VIRUS; HUMAN; IMMUNOLOGY; MALE; PRESCHOOL CHILD; SOCIAL CLASS; SOCIOECONOMICS;

CHILD, PRESCHOOL; CHILE; COHORT STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HEPATITIS A; HEPATITIS A VIRUS; HEPATITIS ANTIBODIES; HEPATITIS E; HEPATITIS E VIRUS; HUMANS; MALE; SEROEPIDEMIOLOGIC STUDIES; SOCIAL CLASS; SOCIOECONOMIC FACTORS;

EID: 33645054578     PISSN: 00349887     EISSN: 07176163     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. TAPIA-CONYER R, SANTOS JI, CAVALCANTT AM, URDANETA E, RIVERA L, MANTEROLA A ET AL. Hepatitis A in Latin America: a changing epidemiologic pattern. Am J Trop Med Hyg 1999; 61: 825-9.
2. LAGOS R, POTIN M, MUÑOZ A ABREGO P, SAN MARTÍN OS, URETA AM ET AL. [Serum antibodies against hepatitis A virus among subjects of middle and low socioeconomic levels in urban area of Santiago Chile]. Rev Méd Chile 1999; 127: 429-36.
3. IBARRA H, RIEDEMANN S, REINHARDT G, TOLEDO C, RIOFRÍO R. Seguimiento de anticuerpos de virus de la hepatitis A y E en niños aparentemente sanos: Informe preliminar. Gastr Latinoam 2000; 11: 384.
4. WEBSTER G, BARNES E, DUSHEIKO G, FRANKLIN I. Protecting travellers from hepatitis A BMJ 2001; 322: 1194-95.
5. ARMSTRONG GL, BELL BP. Hepatitis A virus infection in the United States: model-based estimates and implications for childhood immunization. Pediatrics 2002; 109: 839-45.
6. STROFFOLINI T, DE CRESCENZO L, GIAMMANCO A, INTONAZZO V, LA ROSA G, CASCIO A ET AL. Changing patterns of hepatitis A virus infection in children in Palermo, Italy. Eur J Epidemiol 1990; 6: 84-7.
7. BRIEM H. Declining prevalence of antibodies to hepatitis A virus infection in Iceland. Scand J Infect Dis 1991; 23: 135-8.
8. BRUGUERA M, SALLERAS L, PLANS P, VIDAL J, NAVAS E, DOMÍNGUEZ A ET AL. [Changes in seroepidemiology of hepatitis A virus infection in Catalonia in the period 1989-1996. Implications for new vaccination strategy]. Med Clin (Bare) 1999; 112: 406-8.
9. POLZ-DACEWICZ MA, POLICZKIEWICZ P, BADACH Z. Changing epidemiology of hepatitis A virus infection- a comparative study in Central Eastern Poland (1990-1999) Med Sci Monit 2000; 6: 989-93.
10. POOVORAWAN Y, VIOMOLKEJ T, CHONGSRISAWAT V, THEAMBOONLERS A, CHUMDERMPADETSUK S. The declining pattern of seroepidemiology of hepatitis A virus infection among adolescents in Bangkok, Thailand. Southeast Asian J Trop Med Public Health 1997; 28: 154-7.
11. CHITAMBAR SD, CHADHA MS, JOSHI MS, ARANKALLE VA. Prevalence of hepatitis A antibodies in Western Indian population changing pattern. Southeast Asian J Trop Med Public Health 1999; 30: 273-6.
12. WANG SM LIU CC, HUANG YS, YANG YJ, Da HY. Change in hepatitis A virus seroepidemiology in Southern Taiwan: a large percentage of the population lack protective antibody. J Med Virol 2001; 64: 104-8.
13. IBARRA H, RIEDEMANN S, SIEGEL F, REINHARDT G, TOLEDO C, FROESNER G. Hepatitis E virus in Chile. Lancet 1994; 344: 1501.
14. DIGNANI MC, MICELI MH, ROSA CH GATICA J, MARTÍNEZ-ROLON J, PIZZOLATO M. Loss of hepatitis A virus (HAV) antibodies after peripheral stem cell transplantation. Bone Marrow Transplant 2003; 31: 809-12.
15. JOSHI N, YR NK, KUMAR A Age related seroprevalence of antibodies to hepatitis A virus in Hyderabad, India. Trop Gastroenterol 2000; 21: 63-5.
16. SIDAL M, UNUVAR E, OGUZ F, CIHAN C, ONEL D, BADUR S. Age-specific seroepidemiology of hepatitis A, B, and E infection among children in Istanbul, Turkey. Eur J Epidemiol 2001; 17: 141-4.
17. PEACH D, MCMAHON BJ, BULKOW L, FUNK E, HARPAZ R, MARGOLIS HS. Impact of recurrent epidemics of hepatitis A virus infection on population immunity levels: Bristol Bay, Alaska. J Infect Dis 2002; 186: 1081-5.
18. IBARRA H, RIEDEMANN S, SIEGEL F, TOLEDO C, FROESNER G. [Acute hepatitis caused by virus A, E and non A-E in Chilean adults]. Rev Méd Chile 2001; 129: 523-30.
19. GONZÁLEZ PRAETORIUS A, RODRÍGUEZ-AVIAL C, FERNÁNDEZ C, PÉREZ POMAT MF, GIMENO C, BISQUERT J. Incidence and risk factors for hepatitis A in the province of Guadalajara (Spain). Gastroenterol Hepatol 2002; 25: 230-4.
20. TANAKA J. Hepatitis A shifting epidemiology in Latin America. Vaccine 2000; 18 Suppl 1: S57-60.
21. DENTINGER CM HEINRICH NL, BELL BP, FOX LM, KATZ DJ, CULVER DH ET AL. A prevalence study of hepatitis A virus infection in a migrant community: Is hepatitis A vaccine indicated? J Pediatr 2001; 138: 705-9.
22. AVERHOFF F, SHAPIRO CM, BELL BP, HYAMS I, BURD L, DELADISMA A ET AL. Control of hepatitis A through routine vaccination in children. JAMA 2001; 286: 2968-73.
23. RIEDEMANN S, REINHARDT G, IBARRA H, FROESNER G. Immunogenicity and safety of a virosomal hepatitis A vaccine (Epaxal®) in healthy toddlers and children in Chile. Acta Paediatrica 2004; 93: 4124.
24. GILLIS D, GROTTO I, MIMOUNI D, HUERTA M, GDALEVICH M, SHPILBERG O. Adult infection with hepatitis A despite declining endemiciry; in favor of adult vaccination. Vaccine 2002; 20: 2243-8.